The store will not work correctly when cookies are disabled.
N-[4-(Dimethylamino)benzyl]-N-(5-methyl-3-phenylisoxazol-4-yl)acetamide
ID: ALA4454617
PubChem CID: 155523760
Max Phase: Preclinical
Molecular Formula: C21H23N3O2
Molecular Weight: 349.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)N(Cc1ccc(N(C)C)cc1)c1c(-c2ccccc2)noc1C
Standard InChI: InChI=1S/C21H23N3O2/c1-15-21(20(22-26-15)18-8-6-5-7-9-18)24(16(2)25)14-17-10-12-19(13-11-17)23(3)4/h5-13H,14H2,1-4H3
Standard InChI Key: LSDSVYZSHFRXJT-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
15.5125 -3.0070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5063 -3.8283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2852 -4.0885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7765 -3.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2952 -2.7627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5299 -4.8682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5512 -1.9882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3531 -1.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6113 -1.0507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0687 -0.4385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2645 -0.6061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0100 -1.3804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5936 -3.4353 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9969 -4.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8141 -4.1521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0075 -2.7306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8246 -2.7367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6041 -2.0199 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2136 -4.8661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0300 -4.8725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4447 -4.1673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0370 -3.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2219 -3.4513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2619 -4.1723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6661 -4.8825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6748 -3.4671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
3 6 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
4 13 1 0
13 14 1 0
14 15 1 0
13 16 1 0
16 17 1 0
16 18 2 0
15 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 15 1 0
21 24 1 0
24 25 1 0
24 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 349.43 | Molecular Weight (Monoisotopic): 349.1790 | AlogP: 4.27 | #Rotatable Bonds: 5 |
Polar Surface Area: 49.58 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.85 | CX LogP: 3.50 | CX LogD: 3.50 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.69 | Np Likeness Score: -1.39 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |